Vice President, Early Clinical Development, Oncology

The Company is in search of a Vice President for Early Clinical Development in Oncology. This pivotal role involves leading the clinical development of the company's oncology portfolio, with a focus on advancing programs from discovery into the clinic. The successful candidate will be responsible for developing and owning integrated clinical development plans, defining target product profiles, and establishing pre-specified go/no-go criteria for each program. Additionally, the role requires leadership in IND-enabling clinical planning, first-in-human study design, and execution, as well as the transition of programs into late-stage development. The Vice President will also be at the forefront of biomarker-driven development, and AI-integrated clinical decision-making, and will be expected to have a strong background in oncology, including experience with more than one tumor type and a proven track record in clinical development. Applicants for this role at the company should hold an MD or MD/PhD, with a strong preference for those who have completed residency and fellowship in medical oncology or hematology/oncology. A minimum of 12 years of clinical development experience in the biotechnology or pharmaceutical industry, including at least 5 years in a leadership capacity, is required. The ideal candidate will have a deep understanding of oncology, experience in IND and first-in-human leadership, and a proven ability to transition programs from Phase 1 to late-stage development. Experience in biomarker-driven development, AI, and advanced analytics is essential, as is a strong background in regulatory interactions. The role demands excellent communication skills, the ability to work in a fast-paced environment, and a commitment to building and leading a high-performing clinical development team.